Alteraciones metabólicas y su relación con el índice de masa corporal
DOI:
https://doi.org/10.56048/MQR20225.7.2.2023.1563-1585Palabras clave:
Índice de masa corporal, enfermedad cardiovascular, obesidad, sobrepeso, síndrome metabólico.Resumen
Introducción: La población con sobrepeso y obesos están dentro de los parámetros donde presentan factores que aumentan el riesgo de desarrollar síndrome metabólico como es la dislipidemia, hipertensión arterial, e insulinorresistencia o prediabetes u obesidad central.
Objetivo: Analizar las alteraciones metabólicas y su relación con el índice de masa corporal.
Métodos: Este estudio consiste en una revisión para la cual se recopiló información científica de artículos publicados en revistas indexadas como PubMed y Scopus. Para realizar la búsqueda de información se utilizarán términos relacionados proporcionados por MeSH, así como los operadores booleanos "AND", "NOT" y "OR", que podrán combinarse para obtener resultados más precisos. Para seleccionar la información relevante, se aplicarán criterios de inclusión y exclusión.
Resultados: El IMC es un indicador que, junto con la alteración de uno de los parámetros del síndrome metabólico, sugiere una asociación con enfermedades metabólicas a largo plazo en el paciente.
Conclusiones: un IMC elevado se relaciona con disfunciones metabólicas que aumentan el riesgo de enfermedades crónicas como DM2, CVD y enfermedades del hígado. Es importante detectar tempranamente las alteraciones metabólicas y adoptar un estilo de vida saludable para prevenir complicaciones a largo plazo.
Descargas
Métricas
Cited
DOI: 10.56048
Citas
Afzal, M., Siddiqi, N., Ahmad, B., Afsheen, N., Aslam, F., Ali, A., Rubab Ayesha, Bryant, M., Richard, Khalid, H., Ishaq, K., Kamrun Nahar Koly, Rajan, S., Saba, J., Nilesh Tirbhowan, & Antonio, G. (2021). Prevalence of Overweight and Obesity in People With Severe Mental Illness: Systematic Review and Meta-Analysis. 12. https://doi.org/10.3389/fendo.2021.769309
Agbaje, A. O. (2022). Arterial stiffness precedes hypertension and metabolic risks in youth: a review. 40(10), 1887–1896. https://doi.org/10.1097/hjh.0000000000003239
Bazyar H, Zare Javid A, Bavi Behbahani H, Moradi F, Moradi Poode B, Amiri P (2021). Consumption of melatonin supplement improves cardiovascular disease risk factors and anthropometric indices in type 2 diabetes mellitus patients: a double-blind, randomized, placebo-controlled trial. 22(1). https://doi.org/10.1186/s13063-021-05174-z
Belfort-DeAguiar, R., Seo, D., Lacadie, C., Naik, S., Schmidt, C., Lam, W., Hwang, J. J., Constable, T., Sinha, R., & Sherwin, R. S. (2018). Humans with obesity have disordered brain responses to food images during physiological hyperglycemia. 314(5), E522–E529. https://doi.org/10.1152/ajpendo.00335.2017
Belladelli, F., Montorsi, F., & Martini, A. (2022). Metabolic syndrome, obesity and cancer risk. 32(6), 594–597. https://doi.org/10.1097/mou.0000000000001041
Castro EA, Carraça EV, Cupeiro R, López-Plaza B, Teixeira PJ, González-Lamuño D, et al.. (2020). The Effects of the Type of Exercise and Physical Activity on Eating Behavior and Body Composition in Overweight and Obese Subjects. 12(2), 557–557. https://doi.org/10.3390/nu12020557
Chen, G.-C., Arthur, R., Iyengar, N. M., Kamensky, V., Xue, X., Wassertheil-Smoller, S., Allison, M. A., Shadyab, A. H., Wild, R. A., Sun, Y., Banack, H. R., Jin Choul Chai, Wactawski-Wende, J., Manson, J. E., Stefanick, M. L., Dannenberg, A. J., Rohan, T. E., & Qi, Q. (2019). Association between regional body fat and cardiovascular disease risk among postmenopausal women with normal body mass index. 40(34), 2849–2855. https://doi.org/10.1093/eurheartj/ehz391
Chen, M., Yang, R., Wang, Y., Jia, Y., Liu, J., & Wang, G. (2021). Non-linear associations of body mass index with impaired fasting glucose, β-cell dysfunction, and insulin resistance in nondiabetic Chinese individuals: a cross-sectional study. 72(6), 618–624. https://doi.org/10.5603/ep.a2021.0073
Chooi, Y., Ding, C., & Faidon Magkos. (2019). The epidemiology of obesity. 92, 6–10. https://doi.org/10.1016/j.metabol.2018.09.005
Christoph Reichetzeder. (2021). Overweight and obesity in pregnancy: their impact on epigenetics. 75(12), 1710–1722. https://doi.org/10.1038/s41430-021-00905-6
Dong, G.-H., Perkins, N. J., Sjaarda, L. A., Kannan, K., Ye, A., Kim, K., Kuhr, D. L., Nobles, C. J., Connell, M. T., & Schisterman, E. F. (2021). Adiposity is associated with anovulation independent of serum free testosterone: A prospective cohort study. 35(2), 174–183. https://doi.org/10.1111/ppe.12726
Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, et al. (2022). Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. 23(2), 786–786. https://doi.org/10.3390/ijms23020786
Garifulina, L., Ashurova, M., & Goyibova, N. (2020). Characteristic Of The Cardiovascular System In Children And Adolescents At Obesity In Accompanience Of Arterial Hypertension. European Journal of Molecular & Clinical Medicine, 7(3), 3171–3175. https://ejmcm.com/article_4034.html
Gepner Y, Goldstein N, Shelef I, Schwarzfuchs D, Zelicha H, Meir AY, et al. (2021). Dissociation Between Long-term Weight Loss Intervention and Blood Pressure: an 18-month Randomized Controlled Trial. 36(8), 2300–2306. https://doi.org/10.1007/s11606-021-06655-2
H. Lemamsha, Randhawa, G., & Papadopoulos, C. (2019). Prevalence of Overweight and Obesity among Libyan Men and Women. 2019, 1–16. https://doi.org/10.1155/2019/8531360
James, B. D., Jones, A. V., Trethewey, R., & Evans, R. A. (2017). Obesity and metabolic syndrome in COPD: Is exercise the answer? 15(2), 173–181. https://doi.org/10.1177/1479972317736294
Jin EH, Han K, Lee DH, Shin CM, Lim JH, Choi YJ, et al. (2022). Association Between Metabolic Syndrome and the Risk of Colorectal Cancer Diagnosed Before Age 50 Years According to Tumor Location. 163(3), 637-648.e2. https://doi.org/10.1053/j.gastro.2022.05.032
Johnson, W. D., Norris, T., & Hamer, M. (2021). Secular changes in mid-adulthood body mass index, waist circumference, and low HDL cholesterol between 1990, 2003, and 2018 in Great Britain. 75(3), 539–545. https://doi.org/10.1038/s41430-020-00758-5
Jung YS, Kim, N., Yang, H. J., Sung Keun Park, Jung Tak Park, Dong Il Park, & Chong Il Sohn. (2020). Association between waist circumference and risk of colorectal neoplasia in normal‐weight adults. https://doi.org/10.1111/jgh.14767
Kaze, A. D., Santhanam, P., Musani, S. K., Ahima, R. S., & Allison, M. A. (2021). Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study. 10(7). https://doi.org/10.1161/jaha.120.016947
Kim CH, Han KA, Yu J, Lee SH, Jeon HK, Kim SH, et al (2018). Efficacy and Safety of Adding Omega-3 Fatty Acids in Statin-treated Patients with Residual Hypertriglyceridemia: ROMANTIC (Rosuvastatin-OMAcor iN residual hyperTrIglyCeridemia), a Randomized, Double-blind, and Placebo-controlled Trial. 40(1), 83–94. https://doi.org/10.1016/j.clinthera.2017.11.007
Klein, S., Gastaldelli, A., Hannele Yki-Järvinen, & Scherer, P. E. (2022). Why does obesity cause diabetes? 34(1), 11–20. https://doi.org/10.1016/j.cmet.2021.12.012
Kwobah, E., Koen, N., Mwangi, A., Lukoye Atwoli, & Stein, D. J. (2021). Prevalence and correlates of metabolic syndrome and its components in adults with psychotic disorders in Eldoret, Kenya. 16(1), e0245086–e0245086. https://doi.org/10.1371/journal.pone.0245086
Lee, D., & Lee, J.-A. (2021). Effects of Exercise Interventions on Weight, Body Mass Index, Lean Body Mass and Accumulated Visceral Fat in Overweight and Obese Individuals: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 18(5), 2635–2635. https://doi.org/10.3390/ijerph18052635
Li, D.-T., Zhang, M., Wu, S., Tan, H., & Li, N. (2022). Risk factors and prediction model for nonalcoholic fatty liver disease in northwest China. 12(1). https://doi.org/10.1038/s41598-022-17511-6
Liu, X., Yu, S., Mao, Z., Li, Y., Zhang, H., Yang, K., Zhang, H., Liu, R., Qian, X., Li, L., Bie, R., & Wang, C. (2018). Dyslipidemia prevalence, awareness, treatment, control, and risk factors in Chinese rural population: the Henan rural cohort study. 17(1). https://doi.org/10.1186/s12944-018-0768-7
María, J., & Martínez-Marcos, M. (2018). Sobrepeso y obesidad: eficacia de las intervenciones en adultos. 28(1), 65–74. https://doi.org/10.1016/j.enfcli.2017.06.005
Marie-Eve Piché, André Tchernof, & Jean-Pierre Després. (2020). Obesity Phenotypes, Diabetes, and Cardiovascular Diseases. 126(11), 1477–1500. https://doi.org/10.1161/circresaha.120.316101
Maroofi M, Nasrollahzadeh J. (2020). Effect of intermittent versus continuous calorie restriction on body weight and cardiometabolic risk markers in subjects with overweight or obesity and mild-to-moderate hypertriglyceridemia: a randomized trial. 19(1). https://doi.org/10.1186/s12944-020-01399-0
Mayoral, L., Andrade, G., Mayoral, E., Huerta, T., Pina-Canseco, S., Canales, F., Cabrera-Fuentes, H. A., Margarito Martínez Cruz, Dolores, A., Alpuche, J., Zenteno, E., Ruiz, H. A., Ortega-Dela, R. A., Hernández, J. M., & Pérez-Campos, E. (2020). Obesity subtypes, related biomarkers & heterogeneity. 151(1), 11–11. https://doi.org/10.4103/ijmr.ijmr_1768_17
Mili N, Paschou SA, Goulis DG, Dimopoulos M-A, Lambrinoudaki I, Psaltopoulou T. (2021). Obesity, metabolic syndrome, and cancer: pathophysiological and therapeutic associations. 74(3), 478–497. https://doi.org/10.1007/s12020-021-02884-x
Mulerova, T. A., Ogarkov, M., Evgenya Uchasova, Voevoda, M. I., & Barbarash, O. (2018). A comparison of the genetic and clinical risk factors for arterial hypertension between indigenous and non-indigenous people of the Shoria Mountain Region. 40(4), 324–331. https://doi.org/10.1080/10641963.2017.1377215
Okoth K, Subramanian A, Chandan JS, Adderley NJ, Thomas GN, Nirantharakumar K, et al (2022). Long term miscarriage-related hypertension and diabetes mellitus. Evidence from a United Kingdom population-based cohort study. 17(1), e0261769–e0261769. https://doi.org/10.1371/journal.pone.0261769
Pazoki R, Dehghan A, Evangelou E, Warren H, Gao H, Caulfield M, et al. (2017). Genetic Predisposition to High Blood Pressure and Lifestyle Factors. 137(7), 653–661. https://doi.org/10.1161/circulationaha.117.030898
Purdy, J. C., & Shatzel, J. J. (2021). The hematologic consequences of obesity. 106(3), 306–319. https://doi.org/10.1111/ejh.13560
Ruilope, L. M., A.C.B. Nunes Filho, Nadruz, W., F.F. Rodríguez Rosales, & Verdejo-Paris, J. (2018). Obesity and hypertension in Latin America: Current perspectives. 35(2), 70–76. https://doi.org/10.1016/j.hipert.2017.12.004
Sakane, N., Kotani, K., Suganuma, A., Takahashi, K., Sato, J., Suzuki, S., Izumi, K., Kato, M., Noda, M., Naoki Sakane, & Hideshi Kuzuya. (2020). Effects of obesity, metabolic syndrome, and non‐alcoholic or alcoholic elevated liver enzymes on incidence of diabetes following lifestyle intervention: A subanalysis of the J‐DOIT1. 62(1). https://doi.org/10.1002/1348-9585.12109
Sampson, M. J., Clark, A., Bachmann, M. O., Garner, N. J., Irvine, L., Howe, A., Greaves, C., Auckland, S., Jane McKee Smith, Turner, J., Rea, D., Rayman, G., Ketan Dhatariya, John, W., Barton, G., Usher, R., Ferns, C., & Pascale, M. (2021). Lifestyle Intervention With or Without Lay Volunteers to Prevent Type 2 Diabetes in People With Impaired Fasting Glucose and/or Nondiabetic Hyperglycemia. 181(2), 168–168. https://doi.org/10.1001/jamainternmed.2020.5938
Sangouni AA, Taghdir M, Mirahmadi J, Sepandi M, & Parastouei K. (2022). Effects of curcumin and/or coenzyme Q10 supplementation on metabolic control in subjects with metabolic syndrome: a randomized clinical trial. 21(1). https://doi.org/10.1186/s12937-022-00816-7
Sasaki, R., Yano, Y., Taro Yasuma, Onishi, Y., Suzuki, T., Maruyama-Furuta, N., Gabazza, E. C., Sumida, Y., & Takei, Y. (2016). Association of Waist Circumference and Body Fat Weight with Insulin Resistance in Male Subjects with Normal Body Mass Index and Normal Glucose Tolerance. 55(11), 1425–1432. https://doi.org/10.2169/internalmedicine.55.4100
Sasaki, R., Yano, Y., Taro Yasuma, Onishi, Y., Suzuki, T., Maruyama-Furuta, N., Gabazza, E. C., Sumida, Y., & Takei, Y. (2016). Association of Waist Circumference and Body Fat Weight with Insulin Resistance in Male Subjects with Normal Body Mass Index and Normal Glucose Tolerance. 55(11), 1425–1432. https://doi.org/10.2169/internalmedicine.55.4100
Sato, D., Morino, K., Seiichiro Ogaku, Tsuji, A., Nishimura, K., Sekine, O., Satoshi Ugi, & Hiroshi Maegawa. (2019). Efficacy of metformin on postprandial plasma triglyceride concentration by administration timing in patients with type 2 diabetes mellitus: A randomized cross‐over pilot study. 10(5), 1284–1290. https://doi.org/10.1111/jdi.13016
Shrestha, R., Sanjib Kumar Upadhyay, Khatri, B., Janak Raj Bhattarai, Manish Kayastha, & Upadhyay, M. P. (2021). BMI, waist to height ratio and waist circumference as a screening tool for hypertension in hospital outpatients: a cross-sectional, non-inferiority study. 11(11), e050096–e050096. https://doi.org/10.1136/bmjopen-2021-050096
Stadler, J., & Gunther Marsche. (2020). Obesity-Related Changes in High-Density Lipoprotein Metabolism and Function. 21(23), 8985–8985. https://doi.org/10.3390/ijms21238985
Tang, Z., Minh Tu Pham, Hao, Y., Wang, F., Patel, D., Jean-Baptiste, L., Fan, L., Wang, W.-J., Wang, Y., & Cheng, F. (2019). Sex, Age, and BMI Modulate the Association of Physical Examinations and Blood Biochemistry Parameters and NAFLD: A Retrospective Study on 1994 Cases Observed at Shuguang Hospital, China. 2019, 1–7. https://doi.org/10.1155/2019/1246518
Urióstegui F. A., García-Bravo, L., Pérez-Pinto, A., & Orea-Lara, A. (2018). Medición de parámetros asociados al síndrome metabólico en alumnos de enfermería en Taxco, México. 20(3), 334–339. https://doi.org/10.15446/rsap.v20n3.53837
Wang, T., Xu, J., Fu, L., & Li, L. (2020). Hypertriglyceridemia is associated with platelet hyperactivation in metabolic syndrome patients. 74(7). https://doi.org/10.1111/ijcp.13508
Woo JS, Hong SJ, Cha DH, Kim KS, Kim MH, Lee J-W, et al. (2021). Comparison of the Efficacy and Safety of Atorvastatin 40 mg/ω-3 Fatty Acids 4 g Fixed-dose Combination and Atorvastatin 40 mg Monotherapy in Hypertriglyceridemic Patients who Poorly Respond to Atorvastatin 40 mg Monotherapy: An 8-week, Multicenter, Randomized, Double-blind Phase III Study. 43(8), 1419–1430. https://doi.org/10.1016/j.clinthera.2021.07.001
World. (2021, June 9). Obesidad y sobrepeso. Who.int; World Health Organization: WHO. https://www.who.int/es/news-room/fact-sheets/detail/obesity-and-overweight
Yeung, K.-F., Yu Qi Lee, Foong, M., Gandhi, M., Lam, A., Selly Julianty, Yip, G., Tse, E., Goh, S.-Y., Siew, G., Jin, E., Finkelstein, E. A., Jafar, T. H., Rob, Yee Leong Teoh, Thumboo, J., & Yong Mong Bee. (2022). Baseline characteristics of participants in the Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) Program. 10(5), e002966–e002966. https://doi.org/10.1136/bmjdrc-2022-002966
Yu, K., Liu, X., Rahim Alhamzawi, Becker, F., & Lord, J. (2018). Statistical methods for body mass index: A selective review. 27(3), 798–811. https://doi.org/10.1177/0962280216643117
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2023 MQRInvestigar
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
®
Los autores se comprometen a respetar la información académica de otros autores, y a ceder los derechos de autor a la Revista MQRInvestigar, para que el artículo pueda ser editado, publicado y distribuido. El contenido de los artículos científicos y de las publicaciones que aparecen en la revista es responsabilidad exclusiva de sus autores. La distribución de los artículos publicados se realiza bajo una licencia 
